2616 — CStone Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for CStone Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,738	3,394	1,726	1,042	1,027
Net Total Accounts Receivable
Net Total Receivables	—	—	118	77.1	172
Total Inventory
Total Other Current Assets
Total Current Assets	2,887	3,572	1,958	1,247	1,330
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	22.2	102	188	207	153
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,951	3,763	2,271	1,638	1,662
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	458	727	933	946	850
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	469	808	1,064	1,189	1,205
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	2,482	2,954	1,207	449	457
Total Liabilities & Shareholders' Equity	2,951	3,763	2,271	1,638	1,662
Total Common Shares Outstanding